Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 102

1.

Pharmacological Considerations in Antithymocyte Globulin Exposure Calculation.

Admiraal R, de Witte MA, Huitema A, Nierkens S.

Biol Blood Marrow Transplant. 2019 Mar 27. pii: S1083-8791(19)30207-1. doi: 10.1016/j.bbmt.2019.03.023. [Epub ahead of print] No abstract available.

PMID:
30928628
2.

Galectin-9 and CXCL10 as biomarkers for disease activity in juvenile dermatomyositis: a longitudinal cohort study and multi-cohort validation.

Wienke J, Bellutti Enders F, Lim J, Mertens JS, van den Hoogen LL, Wijngaarde CA, Yeo JG, Meyer A, Otten HG, Fritsch-Stork RDE, Kamphuis SSM, Hoppenreijs EPAH, Armbrust W, van den Berg JM, Hissink Muller PCE, Tekstra J, Hoogendijk JE, Deakin CT, de Jager W, van Roon JAG, van der Pol WL, Nistala K, Pilkington C, de Visser M, Arkachaisri T, Radstake TRDJ, van der Kooi AJ, Nierkens S, Wedderburn LR, van Royen-Kerkhof A, van Wijk F.

Arthritis Rheumatol. 2019 Mar 12. doi: 10.1002/art.40881. [Epub ahead of print]

PMID:
30861625
3.

Cord-Blood-Stem-Cell-Derived Conventional Dendritic Cells Specifically Originate from CD115-Expressing Precursors.

Plantinga M, de Haar CG, Dünnebach E, van den Beemt DAMH, Bloemenkamp KWM, Mokry M, Boelens JJ, Nierkens S.

Cancers (Basel). 2019 Feb 5;11(2). pii: E181. doi: 10.3390/cancers11020181.

4.

Effect of cytomegalovirus reactivation on the time course of systemic host response biomarkers in previously immunocompetent critically ill patients with sepsis: a matched cohort study.

van de Groep K, Nierkens S, Cremer OL, Peelen LM, Klein Klouwenberg PMC, Schultz MJ, Hack CE, van der Poll T, Bonten MJM, Ong DSY; MARS consortium.

Crit Care. 2018 Dec 18;22(1):348. doi: 10.1186/s13054-018-2261-0.

5.

Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide.

Horwitz ME, Wease S, Blackwell B, Valcarcel D, Frassoni F, Boelens JJ, Nierkens S, Jagasia M, Wagner JE, Kuball J, Koh LP, Majhail NS, Stiff PJ, Hanna R, Hwang WYK, Kurtzberg J, Cilloni D, Freedman LS, Montesinos P, Sanz G.

J Clin Oncol. 2019 Feb 10;37(5):367-374. doi: 10.1200/JCO.18.00053. Epub 2018 Dec 4.

6.

Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution.

Kellner JN, Delemarre EM, Yvon E, Nierkens S, Boelens JJ, McNiece I, Olson A, Nieto Y, Ciurea S, Popat U, Ahmed S, Champlin R, Ramos J, Nishimoto M, Ma H, Ke Z, Thall P, Khoury JD, Negrin R, Andersson B, Parmar S.

Oncotarget. 2018 Nov 2;9(86):35611-35622. doi: 10.18632/oncotarget.26242. eCollection 2018 Nov 2.

7.

High-Dimensional Profiling Reveals Heterogeneity of the Th17 Subset and Its Association With Systemic Immunomodulatory Treatment in Non-infectious Uveitis.

Verhagen FH, Hiddingh S, Rijken R, Pandit A, Leijten E, Olde Nordkamp M, Ten Dam-van Loon NH, Nierkens S, Imhof SM, de Boer JH, Radstake TRDJ, Kuiper JJW.

Front Immunol. 2018 Oct 31;9:2519. doi: 10.3389/fimmu.2018.02519. eCollection 2018.

8.

MYD88 p.(L265P) detection on cell-free DNA in liquid biopsies of patients with primary central nervous system lymphoma.

Hiemcke-Jiwa LS, Leguit RJ, Snijders TJ, Bromberg JEC, Nierkens S, Jiwa NM, Minnema MC, Huibers MMH.

Br J Haematol. 2018 Nov 8. doi: 10.1111/bjh.15674. [Epub ahead of print] No abstract available.

PMID:
30408153
9.

EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with cyclosporin A.

Thijs JL, Drylewicz J, Bruijnzeel-Koomen CAFM, Giovannone B, Knol EF, de Bruin-Weller MS, Nierkens S, Hijnen D.

Allergy. 2019 Mar;74(3):613-617. doi: 10.1111/all.13651. Epub 2018 Dec 16. No abstract available.

PMID:
30368864
10.

Innate Immune Recovery Predicts CD4+ T Cell Reconstitution after Hematopoietic Cell Transplantation.

de Koning C, Langenhorst J, van Kesteren C, Lindemans CA, Huitema ADR, Nierkens S, Boelens JJ.

Biol Blood Marrow Transplant. 2019 Apr;25(4):819-826. doi: 10.1016/j.bbmt.2018.10.013. Epub 2018 Oct 23.

PMID:
30359735
11.

Population Pharmacokinetics of Fludarabine in Children and Adults during Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation.

Langenhorst JB, Dorlo TPC, van Maarseveen EM, Nierkens S, Kuball J, Boelens JJ, van Kesteren C, Huitema ADR.

Clin Pharmacokinet. 2019 May;58(5):627-637. doi: 10.1007/s40262-018-0715-9.

12.

Nedd4-Binding Protein 1 and TNFAIP3-Interacting Protein 1 Control MHC-1 Display in Neuroblastoma.

Spel L, Nieuwenhuis J, Haarsma R, Stickel E, Bleijerveld OB, Altelaar M, Boelens JJ, Brummelkamp TR, Nierkens S, Boes M.

Cancer Res. 2018 Dec 1;78(23):6621-6631. doi: 10.1158/0008-5472.CAN-18-0545. Epub 2018 Sep 13.

PMID:
30213788
13.

Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction.

Hiemcke-Jiwa LS, Ten Dam-van Loon NH, Leguit RJ, Nierkens S, Ossewaarde-van Norel J, de Boer JH, Roholl FF, de Weger RA, Huibers MMH, de Groot-Mijnes JDF, Kuiper JJW.

JAMA Ophthalmol. 2018 Oct 1;136(10):1098-1104. doi: 10.1001/jamaophthalmol.2018.2887.

PMID:
30027272
14.

Quantification of total dinutuximab concentrations in neuroblastoma patients with liquid chromatography tandem mass spectrometry.

El Amrani M, Szanto CL, Hack CE, Huitema ADR, Nierkens S, van Maarseveen EM.

Anal Bioanal Chem. 2018 Sep;410(23):5849-5858. doi: 10.1007/s00216-018-1198-0. Epub 2018 Jun 25.

15.

Strategies to Genetically Modulate Dendritic Cells to Potentiate Anti-Tumor Responses in Hematologic Malignancies.

Cornel AM, van Til NP, Boelens JJ, Nierkens S.

Front Immunol. 2018 May 18;9:982. doi: 10.3389/fimmu.2018.00982. eCollection 2018. Review.

16.

Diagnostic markers for CNS lymphoma in blood and cerebrospinal fluid: a systematic review.

van Westrhenen A, Smidt LCA, Seute T, Nierkens S, Stork ACJ, Minnema MC, Snijders TJ.

Br J Haematol. 2018 Aug;182(3):384-403. doi: 10.1111/bjh.15410. Epub 2018 May 29.

17.

Dendritic Cells.

Plantinga M, de Haar C, Nierkens S.

In: Verhoeckx K, Cotter P, López-Expósito I, Kleiveland C, Lea T, Mackie A, Requena T, Swiatecka D, Wichers H, editors. The Impact of Food Bioactives on Health: in vitro and ex vivo models [Internet]. Cham (CH): Springer; 2015. Chapter 17.

18.

How to define and measure thymopoiesis after transplantation?

de Koning C, Nierkens S, Jan Boelens J.

Bone Marrow Transplant. 2018 Oct;53(10):1364-1365. doi: 10.1038/s41409-018-0199-0. Epub 2018 May 3. No abstract available.

PMID:
29725110
19.

"Immune" Thrombocytopenia as Key Feature of a Novel ADA2 Deficiency Variant: Implication on Differential Diagnostics of ITP in Children.

Sundin M, Marits P, Nierkens S, Kolios AGA, Nilsson J.

J Pediatr Hematol Oncol. 2019 Mar;41(2):155-157. doi: 10.1097/MPH.0000000000001132.

PMID:
29620681
20.

Filgrastim enhances T-cell clearance by antithymocyte globulin exposure after unrelated cord blood transplantation.

de Koning C, Gabelich JA, Langenhorst J, Admiraal R, Kuball J, Boelens JJ, Nierkens S.

Blood Adv. 2018 Mar 13;2(5):565-574. doi: 10.1182/bloodadvances.2017015487.

Supplemental Content

Loading ...
Support Center